Mass General Brigham researchers used long-term data and a blood test for the biomarker pTau217 to identify the earliest signs of Alzheimer’s disease in cognitively healthy adults.

(Kaboompics.com/Pexels/Canva) A blood test shows significant promise for predicting the earliest stages of Alzheimer's ...

A new study​ finds that a simple blood test could predict Alzheimer's disease long before symptoms appear.

Plasma pTau217 may detect initial buildup of AD-related brain changes before they can be detected by current ‘gold standard’ ...

A study suggests that a blood test measuring the biomarker pTau217 can detect early signs of Alzheimer’s disease years before ...

Boston scientists say a routine blood draw might spot the earliest changes of Alzheimer’s long before the brain lights up on ...

Can a blood test predict Alzheimer’s? New research shows the pTau217 biomarker detects amyloid accumulation and cognitive ...

A new study from Mass General Brigham suggests a blood test may detect early biological signs of Alzheimer’s disease earlier ...

HOUSTON, Texas (KTRK) -- According to the Centers for Disease Control, 50% of concussions go unreported. That's scary to think about because there are millions of traumatic brain injury (TBI) ...

A study by investigators at Mass General Brigham has found that a blood test of plasma phosphorylated tau 217 (pTau217), an ...